skip to Global Navigation Bar skip to main content

homeHome > About Us > Recruitment > News


News Content
The U.S. 3-phase clinical results of ‘Jeuveau’ is published on an SCI-level international journal
Date 2019-03-25 Hit 1493
News List
Prev Daewoong Pharmaceutical acquires the sales rights for Vivotif, an orally injected typhoid fever vaccine.
Next Daewoong Pharmaceutical has released ‘Olomax’ for both hypertension and hyperlipidemia